NKG2D-independent suppression of T cell proliferation by H60 and MICA

Anja K Kriegeskorte1, Friedemann E Gebhardt, Simona Porcellini

  • 1Institute for Medical Microbiology, Immunology, and Hygiene, Technical University Munich, 81675 Munich, Germany.

Insights

Certain NKG2D ligands, H60 and MICA, can suppress T cell proliferation. This suppression requires IL-10 and a receptor distinct from NKG2D, offering insights into immune responses against tumors.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • The NKG2D receptor-ligand system is crucial for immune surveillance, typically activating natural killer (NK) and CD8+ T cells against stressed or tumor cells.
  • Previously, all known NKG2D ligands were thought to induce stimulatory effects, positioning NKG2D as a key sensor for immune activation.

Purpose of the Study:

  • To investigate the functional dichotomy of NKG2D ligands, specifically examining if they can also mediate suppressive immune effects.
  • To elucidate the mechanisms underlying potential suppressive functions of NKG2D ligands, including the involvement of specific cytokines and receptors.

Main Methods:

  • Utilized cell-based assays to assess the impact of H60 and MICA on T cell proliferation.
  • Investigated the role of interleukin-10 (IL-10) and alternative receptors in mediating the observed suppressive effects.

Main Results:

  • Demonstrated that NKG2D ligands H60 and MICA can induce significant suppression of T cell proliferation, contrasting with previously understood stimulatory roles.
  • Established that IL-10 is essential for H60- and MICA-mediated T cell suppression.
  • Identified that the suppressive pathway involves a receptor distinct from NKG2D.

Conclusions:

  • The NKG2D system exhibits a dual function, with certain ligands (H60, MICA) capable of suppressing T cell responses, not just activating them.
  • Findings suggest a novel mechanism for immune evasion in cancer, explaining why high NKG2D ligand expression on tumors may not always lead to effective anti-tumor immunity.
  • Highlights a distinct subgroup of NKG2D ligands that mediate immune suppression, mediated by IL-10 and a non-NKG2D receptor.